Kyverna Therapeutics, Inc. (KYTX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $5.0K | -99.8% |
| 2024 | $2.21M | +255.1% |
| 2023 | $621.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $5.0K | -99.8% |
| 2024 | $2.21M | +255.1% |
| 2023 | $621.0K | — |